The Market Today
Provided by Schwab Center for Investment Research
Unable to hold early gains, stocks slid late in the session to finish slightly lower as lingering geopolitical uncertainties boosted the price of crude oil, offsetting mostly upbeat corporate headlines. Goldman Sachs (GS 7,10) handily beat the Street's profit forecast, Eastman Chemical (EMN 7) raised guidance and Elan (ELN 7) said it will file for early approval of a new drug. Treasurys were slightly higher in the absence of market-moving economic data. The Dow Jones Industrial Average fell 0.01%, the S&P 500 Index was 0.1% lower and the Nasdaq Composite Index dropped 0.4%. Biotech and oil service shares were among the worst performers, while chemical shares led to the upside. A moderate 1.4 billion shares changed hands on the Big Board, as 1.8 billion shares traded on the Nasdaq.